Polymorphisms of antipyrine and theophylline metabolism in man: Molecular and clinical implications
- 1 January 1986
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 16 (5) , 401-420
- https://doi.org/10.3109/00498258609050248
Abstract
1. In normal subjects under carefully controlled uniform environmental conditions, evidence was obtained for genetically controlled polymorphisms of antipyrine and theophylline metabolism. 2. The relationship of these polymorphisms to each other and to previously described polymorphisms is discussed in terms of their molecular and clinical implications.This publication has 81 references indexed in Scilit:
- Nutritional Influences on Chemical Biotransformations in HumansNutrition Reviews, 2009
- Polymorphism of theophylline metabolism in man.Journal of Clinical Investigation, 1985
- Assessment of Methods to Identify Sources of Interindividual Pharmacokinetic VariationsClinical Pharmacokinetics, 1983
- Ethnic Differences in Drug MetabolismClinical Pharmacokinetics, 1982
- Nortriptyline and antipyrine clearance in relation to debrisoquine hydroxylation in manLife Sciences, 1980
- Evaluation of the absorption from 15 commercial theophylline products indicating deficiencies in currently applied bioavailability criteriaJournal of Pharmacokinetics and Biopharmaceutics, 1980
- Relationship of theophylline clearance to oral dosage in children with chronic asthmaThe Journal of Pediatrics, 1977
- DIPHENYLHYDANTOIN HALF‐LIFE IN MAN AND ITS INHIBITION BY PHENYLBUTAZONE: THE ROLE OF GENETIC FACTORSActa Medica Scandinavica, 1973
- Genetic control of dicumarol levels in manJournal of Clinical Investigation, 1968
- Genetic Control of Drug Levels in Man: PhenylbutazoneScience, 1968